Accessibility

A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close

Alex Halpern

2nd year, NY program

Alex Halpern

Efficacy of alemtuzumab treatment in active relapsing remitting multiple sclerosis : A study of real world evidence. 5.7.19

Dr. Ophir Zmira, Neurology

Efficacy of Alemtuzumab treatment in active RRMS- A real-life study